Bionano Genomics (MEX:BNGO) Stock Based Compensation : MXN163.5 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Bionano Genomics Stock Based Compensation?

Bionano Genomics's Stock Based Compensation for the three months ended in Mar. 2025 was MXN32.5 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 was MXN163.5 Mil.

Bionano Genomics Stock Based Compensation Historical Data

The historical data trend for Bionano Genomics's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionano Genomics Stock Based Compensation Chart

Bionano Genomics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Stock Based Compensation

Get a 7-Day Free Trial

30.91

199.38

437.04

257.64

203.05

Bionano Genomics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Stock Based Compensation	Get a 7-Day Free Trial															50.04	47.32	43.36	40.38	32.47

Bionano Genomics Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN163.5 Mil.

Bionano Genomics Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Bionano Genomics's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionano Genomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bionano Genomics Inc (MEX:BNGO) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

BNGO:USA

Address

9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121

Website

https://www.bionano.com

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.